Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis.
about
β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children.Pharmacological rationale for the use of somatostatin and analogues in portal hypertension.Role of echo Doppler ultrasonography in the evaluation of postprandial hyperemia in cirrhotic patients.NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.
P2860
Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Haemodynamic effects of propra ...... ia in patients with cirrhosis.
@en
Haemodynamic effects of propra ...... ia in patients with cirrhosis.
@nl
type
label
Haemodynamic effects of propra ...... ia in patients with cirrhosis.
@en
Haemodynamic effects of propra ...... ia in patients with cirrhosis.
@nl
prefLabel
Haemodynamic effects of propra ...... ia in patients with cirrhosis.
@en
Haemodynamic effects of propra ...... ia in patients with cirrhosis.
@nl
P2093
P1476
Haemodynamic effects of propra ...... mia in patients with cirrhosis
@en
P2093
P304
P356
10.1097/00042737-200102000-00012
P577
2001-02-01T00:00:00Z